SPECT and neuropsychological measures of lithium toxicity.
William
W
Sheehan
Steven
S
Thurber
D000368:Aged; D018692:Antimanic Agents / Q000627:therapeutic use / Q000633:toxicity*; D001714:Bipolar Disorder / Q000000981:diagnostic imaging / Q000188:drug therapy*; D001921:Brain / Q000000981:diagnostic imaging / Q000187:drug effects*; D002531:Cerebellum / Q000000981:diagnostic imaging / Q000187:drug effects; D003987:Dibenzothiazepines / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D004359:Drug Therapy, Combination; D006801:Humans; D016651:Lithium Carbonate / Q000627:therapeutic use / Q000633:toxicity*; D008140:Lorazepam / Q000627:therapeutic use; D008297:Male; D009483:Neuropsychological Tests; D000069348:Quetiapine Fumarate; D015899:Tomography, Emission-Computed, Single-Photon
D018692:Antimanic Agents; D003987:Dibenzothiazepines; D016651:Lithium Carbonate; D000069348:Quetiapine Fumarate; D008140:Lorazepam